Tapewire

Nasdaq · USD

PRAX

Praxis Precision Medicines, Inc.

Export transactions ↓
Tapewire entity
3538
SEC CIK
0001689548
Parsed reports
206

Last 12 months

Inside the activity.

0 purchase rows · 18 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202506
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 2026012
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 29, 2024 Filed Aug 1, 2024 01:00 UTC
Kelly Timothy EdwinChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 36,400 $0.00 Strike: $56.94 $0.00
Disclosure

SEC source: 0001104659-24-084502 · tm2420554-1_4seq1.xml · derivative · entry 2

Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,400

Underlying: Common Stock · 36,400 shares

Expires 2034-07-29

F2 · derivative.exercise_date: The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the reporting person's continued service through each vesting date.

Read SEC document
July 29, 2024 Filed Aug 1, 2024 01:00 UTC
Kelly Timothy EdwinChief Financial Officer
GrantCommon Stock 7,800 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-084502 · tm2420554-1_4seq1.xml · nonDerivative · entry 1

Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,140

F1 · shares: Mr. Kelly was awarded 7,800 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 12, 2025, subject to the reporting person's continued service through each vesting date. The restricted stock units have no expiration date.

Read SEC document
July 29, 2024 Filed Aug 1, 2024 01:03 UTC
Souza MarcioDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 185,000 $0.00 Strike: $56.94 $0.00
Disclosure

SEC source: 0001104659-24-084506 · tm2420554-4_4seq1.xml · derivative · entry 1

Souza Marcio · CIK 0001707657 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,000

Underlying: Common Stock · 185,000 shares

Expires 2034-07-29

F1 · derivative.exercise_date: The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the reporting person's continued service through each vesting date.

Read SEC document
July 29, 2024 Filed Aug 1, 2024 01:02 UTC
Nemiroff AlexGeneral Counsel and Secretary
GrantStock Option (Right to Buy) · Derivative 36,400 $0.00 Strike: $56.94 $0.00
Disclosure

SEC source: 0001104659-24-084505 · tm2420554-3_4seq1.xml · derivative · entry 2

Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,400

Underlying: Common Stock · 36,400 shares

Expires 2034-07-29

F2 · derivative.exercise_date: The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the reporting person's continued service through each vesting date.

Read SEC document
July 29, 2024 Filed Aug 1, 2024 01:02 UTC
Nemiroff AlexGeneral Counsel and Secretary
GrantCommon Stock 7,800 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-084505 · tm2420554-3_4seq1.xml · nonDerivative · entry 1

Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,957

F1 · shares: Mr. Nemiroff was awarded 7,800 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 12, 2025, subject to the reporting person's continued service through each vesting date. The restricted stock units have no expiration date.

Read SEC document
July 29, 2024 Filed Aug 1, 2024 01:01 UTC
Mastrocola LaurenPrincipal Accounting Officer
GrantStock Option (Right to Buy) · Derivative 21,000 $0.00 Strike: $56.94 $0.00
Disclosure

SEC source: 0001104659-24-084504 · tm2420554-2_4seq1.xml · derivative · entry 2

Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,000

Underlying: Common Stock · 21,000 shares

Expires 2034-07-29

F2 · derivative.exercise_date: The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the reporting person's continued service through each vesting date.

Read SEC document
July 29, 2024 Filed Aug 1, 2024 01:01 UTC
Mastrocola LaurenPrincipal Accounting Officer
GrantCommon Stock 4,500 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-084504 · tm2420554-2_4seq1.xml · nonDerivative · entry 1

Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,427

F1 · shares: Ms. Mastrocola was awarded 4,500 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 12, 2025, subject to the reporting person's continued service through each vesting date. The restricted stock units have no expiration date.

Read SEC document
June 05, 2024 Filed Jun 6, 2024 22:56 UTC GrantStock Option (Right to Buy) · Derivative 8,566 $0.00 Strike: $44.25 $0.00
Disclosure

SEC source: 0001689548-24-000079 · wk-form4_1717714580.xml · derivative · entry 1

DeSimone Jill · CIK 0001930479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,566

Underlying: Common Stock · 8,566 shares

Expires 2034-06-05

F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on June 5, 2024.

Read SEC document
June 05, 2024 Filed Jun 6, 2024 22:56 UTC GrantStock Option (Right to Buy) · Derivative 8,566 $0.00 Strike: $44.25 $0.00
Disclosure

SEC source: 0001689548-24-000078 · wk-form4_1717714567.xml · derivative · entry 1

MITCHELL DEAN J · CIK 0001199297 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,566

Underlying: Common Stock · 8,566 shares

Expires 2034-06-05

F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on June 5, 2024.

Read SEC document
June 05, 2024 Filed Jun 6, 2024 22:56 UTC GrantStock Option (Right to Buy) · Derivative 8,566 $0.00 Strike: $44.25 $0.00
Disclosure

SEC source: 0001689548-24-000077 · wk-form4_1717714554.xml · derivative · entry 1

Chodakewitz Jeffrey · CIK 0001610876 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,566

Underlying: Common Stock · 8,566 shares

Expires 2034-06-05

F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on June 5, 2024.

Read SEC document
June 05, 2024 Filed Jun 6, 2024 22:55 UTC GrantStock Option (Right to Buy) · Derivative 8,566 $0.00 Strike: $44.25 $0.00
Disclosure

SEC source: 0001689548-24-000076 · wk-form4_1717714540.xml · derivative · entry 1

Cudkowicz Merit Ester · CIK 0001856299 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,566

Underlying: Common Stock · 8,566 shares

Expires 2034-06-05

F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on June 5, 2024.

Read SEC document
June 05, 2024 Filed Jun 6, 2024 22:55 UTC GrantStock Option (Right to Buy) · Derivative 8,566 $0.00 Strike: $44.25 $0.00
Disclosure

SEC source: 0001689548-24-000075 · wk-form4_1717714526.xml · derivative · entry 1

YOUNG WILLIAM D · CIK 0001217420 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,566

Underlying: Common Stock · 8,566 shares

Expires 2034-06-05

F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on June 5, 2024.

Read SEC document
June 05, 2024 Filed Jun 6, 2024 22:55 UTC GrantStock Option (Right to Buy) · Derivative 8,566 $0.00 Strike: $44.25 $0.00
Disclosure

SEC source: 0001689548-24-000074 · wk-form4_1717714512.xml · derivative · entry 1

Norden Gregory · CIK 0001405104 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,566

Underlying: Common Stock · 8,566 shares

Expires 2034-06-05

F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on June 5, 2024.

Read SEC document
May 14, 2024 Filed May 20, 2024 12:10 UTC
Kelly Timothy EdwinChief Financial Officer
GrantCommon Stock 606 $12.37 $7,495.01
Disclosure

SEC source: 0001689548-24-000064 · wk-form4_1716207028.xml · nonDerivative · entry 1

Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,340

F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
May 14, 2024 Filed May 20, 2024 12:10 UTC
Souza MarcioDirector · Chief Executive Officer
GrantCommon Stock 1,718 $12.37 $21,248.22
Disclosure

SEC source: 0001689548-24-000063 · wk-form4_1716207004.xml · nonDerivative · entry 1

Souza Marcio · CIK 0001707657 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,894

F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
February 12, 2024 Filed Feb 14, 2024 21:10 UTC
Souza MarcioDirector · Chief Executive Officer
Tax withholdingCommon Stock 271 $44.65 $12,100.15
Disclosure

SEC source: 0001689548-24-000025 · wk-form4_1707945012.xml · nonDerivative · entry 1

Souza Marcio · CIK 0001707657 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,176

F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 21:14 UTC
Mastrocola LaurenPrincipal Accounting Officer
Tax withholdingCommon Stock 48 $44.65 $2,143.20
Disclosure

SEC source: 0001689548-24-000027 · wk-form4_1707945236.xml · nonDerivative · entry 1

Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,927

F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 21:12 UTC
Nemiroff AlexGeneral Counsel and Secretary
Tax withholdingCommon Stock 51 $44.65 $2,277.15
Disclosure

SEC source: 0001689548-24-000026 · wk-form4_1707945111.xml · nonDerivative · entry 1

Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,157

F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units.

Read SEC document
January 12, 2024 Filed Jan 17, 2024 21:51 UTC
Kelly Timothy EdwinChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $43.37 $0.00
Disclosure

SEC source: 0001689548-24-000021 · wk-form4_1705528288.xml · derivative · entry 1

Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-01-12

F1 · derivative.exercise_date: The shares underlying this stock option vest as follows: 50% vested in full on January 12, 2024 (the "Grant Date") and the remaining 50% vesting over a four-year period, with 25% of such shares vesting on the first anniversary of the Grant Date and the remaining shares vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date.

Read SEC document
January 12, 2024 Filed Jan 17, 2024 21:49 UTC
Souza MarcioDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $43.37 $0.00
Disclosure

SEC source: 0001689548-24-000020 · wk-form4_1705528185.xml · derivative · entry 1

Souza Marcio · CIK 0001707657 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2034-01-12

F1 · derivative.exercise_date: The shares underlying this stock option vest as follows: 50% vested in full on January 12, 2024 (the "Grant Date") and the remaining 50% vesting over a four-year period, with 25% of such shares vesting on the first anniversary of the Grant Date and the remaining shares vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date.

Read SEC document
January 12, 2024 Filed Jan 17, 2024 21:48 UTC
Nemiroff AlexGeneral Counsel and Secretary
GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $43.37 $0.00
Disclosure

SEC source: 0001689548-24-000019 · wk-form4_1705528127.xml · derivative · entry 1

Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-01-12

F1 · derivative.exercise_date: The shares underlying this stock option vest as follows: 50% vested in full on January 12, 2024 (the "Grant Date") and the remaining 50% vesting over a four-year period, with 25% of such shares vesting on the first anniversary of the Grant Date and the remaining shares vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date.

Read SEC document
January 12, 2024 Filed Jan 17, 2024 21:47 UTC
Mastrocola LaurenPrincipal Accounting Officer
GrantStock Option (Right to Buy) · Derivative 12,000 $0.00 Strike: $43.37 $0.00
Disclosure

SEC source: 0001689548-24-000018 · wk-form4_1705528014.xml · derivative · entry 1

Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2034-01-12

F1 · derivative.exercise_date: The shares underlying this stock option vest as follows: 50% vested in full on January 12, 2024 (the "Grant Date") and the remaining 50% vesting over a four-year period, with 25% of such shares vesting on the first anniversary of the Grant Date and the remaining shares vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date.

Read SEC document
January 07, 2024 Filed Jan 10, 2024 02:11 UTC
Kelly Timothy EdwinChief Financial Officer
Tax withholdingCommon Stock 139 $25.19 $3,501.41
Disclosure

SEC source: 0001689548-24-000008 · wk-form4_1704852697.xml · nonDerivative · entry 1

Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,734

F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units.

Read SEC document
January 07, 2024 Filed Jan 10, 2024 02:09 UTC
Souza MarcioDirector · Chief Executive Officer
Tax withholdingCommon Stock 418 $25.19 $10,529.42
Disclosure

SEC source: 0001689548-24-000006 · wk-form4_1704852568.xml · nonDerivative · entry 1

Souza Marcio · CIK 0001707657 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,447

F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units.

Read SEC document
January 07, 2024 Filed Jan 10, 2024 02:10 UTC
Nemiroff AlexGeneral Counsel and Secretary
Tax withholdingCommon Stock 89 $25.19 $2,241.91
Disclosure

SEC source: 0001689548-24-000007 · wk-form4_1704852610.xml · nonDerivative · entry 1

Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,208

F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units.

Read SEC document
January 07, 2024 Filed Jan 10, 2024 02:08 UTC
Mastrocola LaurenPrincipal Accounting Officer
Tax withholdingCommon Stock 35 $25.19 $881.65
Disclosure

SEC source: 0001689548-24-000005 · wk-form4_1704852471.xml · nonDerivative · entry 1

Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,975

F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units.

Read SEC document
October 05, 2023 Filed Oct 10, 2023 11:41 UTC PurchaseCommon Stock 14,500 $1.75 $25,375.00
Disclosure

SEC source: 0001689548-23-000141 · wk-form4_1696938091.xml · nonDerivative · entry 1

DeSimone Jill · CIK 0001930479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,500

Read SEC document
June 27, 2023 Filed Jun 27, 2023 23:52 UTC
Souza MarcioDirector · Chief Executive Officer
PurchaseCommon Stock 10,000 $1.06 $10,587.00
Disclosure

SEC source: 0001689548-23-000115 · wf-form4_168790990907113.xml · nonDerivative · entry 1

Souza Marcio · CIK 0001707657 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by spouse

Disclosed balance after: 45,001.75

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.045 to $1.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.

Read SEC document
June 12, 2023 Filed Jun 14, 2023 11:14 UTC GrantStock Option (Right to Buy) · Derivative 28,981 $0.00 Strike: $0.96 $0.00
Disclosure

SEC source: 0001689548-23-000111 · wf-form4_168674123401611.xml · derivative · entry 1

DeSimone Jill · CIK 0001930479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,981

Underlying: Common Stock · 28,981 shares

Expires 2033-06-12

F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on June 12, 2023.

Read SEC document
June 12, 2023 Filed Jun 14, 2023 11:13 UTC GrantStock Option (Right to Buy) · Derivative 28,981 $0.00 Strike: $0.96 $0.00
Disclosure

SEC source: 0001689548-23-000110 · wf-form4_168674121504095.xml · derivative · entry 1

Chodakewitz Jeffrey · CIK 0001610876 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,981

Underlying: Common Stock · 28,981 shares

Expires 2033-06-12

F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on June 12, 2023.

Read SEC document
June 12, 2023 Filed Jun 14, 2023 11:13 UTC GrantStock Option (Right to Buy) · Derivative 28,981 $0.00 Strike: $0.96 $0.00
Disclosure

SEC source: 0001689548-23-000109 · wf-form4_168674119773018.xml · derivative · entry 1

YOUNG WILLIAM D · CIK 0001217420 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,981

Underlying: Common Stock · 28,981 shares

Expires 2033-06-12

F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on June 12, 2023.

Read SEC document
June 12, 2023 Filed Jun 14, 2023 11:13 UTC GrantStock Option (Right to Buy) · Derivative 28,981 $0.00 Strike: $0.96 $0.00
Disclosure

SEC source: 0001689548-23-000108 · wf-form4_168674118038925.xml · derivative · entry 1

Cudkowicz Merit Ester · CIK 0001856299 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,981

Underlying: Common Stock · 28,981 shares

Expires 2033-06-12

F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on June 12, 2023.

Read SEC document
June 12, 2023 Filed Jun 14, 2023 11:12 UTC GrantStock Option (Right to Buy) · Derivative 28,981 $0.00 Strike: $0.96 $0.00
Disclosure

SEC source: 0001689548-23-000107 · wf-form4_168674116209042.xml · derivative · entry 1

Norden Gregory · CIK 0001405104 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,981

Underlying: Common Stock · 28,981 shares

Expires 2033-06-12

F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on June 12, 2023.

Read SEC document
June 12, 2023 Filed Jun 14, 2023 11:12 UTC GrantStock Option (Right to Buy) · Derivative 28,981 $0.00 Strike: $0.96 $0.00
Disclosure

SEC source: 0001689548-23-000106 · wf-form4_168674114401080.xml · derivative · entry 1

MITCHELL DEAN J · CIK 0001199297 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,981

Underlying: Common Stock · 28,981 shares

Expires 2033-06-12

F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on June 12, 2023.

Read SEC document
May 12, 2023 Filed May 19, 2023 01:49 UTC
Kelly Timothy EdwinChief Financial Officer
GrantCommon Stock 11,683 $0.88 $10,327.77
Disclosure

SEC source: 0001689548-23-000092 · wf-form4_168446094488318.xml · nonDerivative · entry 1

Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,099

F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
May 12, 2023 Filed May 19, 2023 01:47 UTC
Souza MarcioDirector · Chief Executive Officer
GrantCommon Stock 11,687 $0.88 $10,331.31
Disclosure

SEC source: 0001689548-23-000090 · wf-form4_168446079770828.xml · nonDerivative · entry 1

Souza Marcio · CIK 0001707657 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 237,986

F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
May 12, 2023 Filed May 19, 2023 01:47 UTC
Nemiroff AlexGeneral Counsel and Secretary
GrantCommon Stock 11,686 $0.88 $10,330.42
Disclosure

SEC source: 0001689548-23-000091 · wf-form4_168446085671144.xml · nonDerivative · entry 1

Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,460

F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
March 24, 2023 Filed Mar 27, 2023 17:10 UTC
Kelly Timothy EdwinChief Financial Officer
PurchaseCommon Stock 8,000 $0.87 $6,997.60
Disclosure

SEC source: 0001104659-23-037021 · tm2310645-1_4seq1.xml · nonDerivative · entry 1

Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,416

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.861 to $0.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.

Read SEC document
March 24, 2023 Filed Mar 27, 2023 17:11 UTC PurchaseCommon Stock 50,000 $0.84 $41,815.00
Disclosure

SEC source: 0001104659-23-037022 · tm2310645-2_4seq1.xml · nonDerivative · entry 1

MITCHELL DEAN J · CIK 0001199297 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8297 to $0.8596, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.

Read SEC document
March 24, 2023 Filed Apr 6, 2023 21:43 UTC Amendment
Kelly Timothy EdwinChief Financial Officer
PurchaseCommon Stock 8,000 $0.87 $6,997.60
Disclosure

SEC source: 0001104659-23-042818 · tm2312024-1_4aseq1.xml · nonDerivative · entry 1

Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,416

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.861 to $0.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.

Read SEC document
March 23, 2023 Filed Mar 27, 2023 17:12 UTC
Souza MarcioDirector · Chief Executive Officer
PurchaseCommon Stock 35,001.75 $0.86 $30,206.51
Disclosure

SEC source: 0001104659-23-037023 · tm2310645-3_4seq1.xml · nonDerivative · entry 2

Souza Marcio · CIK 0001707657 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by spouse

Disclosed balance after: 35,001.75

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8572 to $0.8676, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.

Read SEC document
March 23, 2023 Filed Mar 27, 2023 17:12 UTC
Souza MarcioDirector · Chief Executive Officer
PurchaseCommon Stock 35,000 $0.86 $30,159.50
Disclosure

SEC source: 0001104659-23-037023 · tm2310645-3_4seq1.xml · nonDerivative · entry 1

Souza Marcio · CIK 0001707657 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 226,299

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.86 to $0.863, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.

Read SEC document
February 12, 2023 Filed Feb 14, 2023 01:50 UTC
Sweeny NicoleChief Commercial Officer
Tax withholdingCommon Stock 1,456 $3.94 $5,736.64
Disclosure

SEC source: 0001689548-23-000051 · wf-form4_167633939597330.xml · nonDerivative · entry 1

Sweeny Nicole · CIK 0001827505 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,619

F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units.

Read SEC document
February 12, 2023 Filed Feb 14, 2023 01:43 UTC
Mastrocola LaurenPrincipal Accounting Officer
Tax withholdingCommon Stock 711 $3.94 $2,801.34
Disclosure

SEC source: 0001689548-23-000048 · wf-form4_167633900969675.xml · nonDerivative · entry 1

Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,160

F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units.

Read SEC document
February 12, 2023 Filed Feb 14, 2023 01:45 UTC
Nemiroff AlexGeneral Counsel and Secretary
Tax withholdingCommon Stock 920 $3.94 $3,624.80
Disclosure

SEC source: 0001689548-23-000049 · wf-form4_167633907475346.xml · nonDerivative · entry 1

Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,774

F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 12:49 UTC
Kelly Timothy EdwinChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 42,455 $0.00 Strike: $2.96 $0.00
Disclosure

SEC source: 0001689548-23-000018 · wf-form4_167361412920494.xml · derivative · entry 1

Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,455

Underlying: Common Stock · 42,455 shares

Expires 2033-01-12

F1 · shares: Mr. Kelly opted to receive this option grant in lieu of a cash bonus for the fiscal year ended December 31, 2022.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 12:47 UTC
Souza MarcioDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 213,975 $0.00 Strike: $2.96 $0.00
Disclosure

SEC source: 0001689548-23-000017 · wf-form4_167361403910614.xml · derivative · entry 1

Souza Marcio · CIK 0001707657 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 213,975

Underlying: Common Stock · 213,975 shares

Expires 2033-01-12

F1 · shares: Mr. Souza opted to receive this option grant in lieu of a cash bonus for the fiscal year ended December 31, 2022.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 12:45 UTC
Sweeny NicoleChief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 41,085 $0.00 Strike: $2.96 $0.00
Disclosure

SEC source: 0001689548-23-000016 · wf-form4_167361390389054.xml · derivative · entry 1

Sweeny Nicole · CIK 0001827505 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,085

Underlying: Common Stock · 41,085 shares

Expires 2033-01-12

F1 · shares: Ms. Sweeny opted to receive this option grant in lieu of a cash bonus for the fiscal year ended December 31, 2022.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 12:43 UTC
Mastrocola LaurenPrincipal Accounting Officer
GrantStock Option (Right to Buy) · Derivative 3,110 $0.00 Strike: $2.96 $0.00
Disclosure

SEC source: 0001689548-23-000015 · wf-form4_167361377763317.xml · derivative · entry 1

Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,110

Underlying: Common Stock · 3,110 shares

Expires 2033-01-12

F1 · shares: Ms. Mastrocola opted to receive this option grant in lieu of a cash bonus for the fiscal year ended December 31, 2022.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 12:41 UTC
Nemiroff AlexGeneral Counsel and Secretary
GrantStock Option (Right to Buy) · Derivative 36,520 $0.00 Strike: $2.96 $0.00
Disclosure

SEC source: 0001689548-23-000014 · wf-form4_167361370297959.xml · derivative · entry 1

Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,520

Underlying: Common Stock · 36,520 shares

Expires 2033-01-12

F1 · shares: Mr. Nemiroff opted to receive this option grant in lieu of a cash bonus for the fiscal year ended December 31, 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.